Ebola Treatment Device Approved For Testing By FDA

The U.S. Food and Drug Administration (FDA) has approved the testing of an Aethlon Medical bro-filtration device on Ebola patients called Hemopurifier that has already been used to illicit a full recovery in a critically ill German patient, according to Reuters.

The device works by filtering viruses and toxins from the blood and is currently being tested in India to lower viral loads in combination with standard Hepatitis C treatments.

"The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions," the company stated, according to its website.

Treatment protocol will be conducted at up to 10 locations in the United States, with up to 20 subjects enrolled during the trial period. Each patient will receive a six to eight hour administration via the therapy, until the virus loads drop below 1,000 copies per milliliter in the samples.

The German study conducted at Frankfurt University Hospital helped reduce a patient's viral load from 400,000 copies per milliliter to 1,000 copies per milliliter in a span of only six and a half hours using Aethlon's Hemopurifier.

The outbreak has killed 7,905 people so far and until a vaccine or treatment is available, many will continue to suffer at the hands of the virus. 

Ebola symptoms include but are not limited to fever, headache, muscle pain, fatigue, diarrhea, vomiting, abdominal pain and unexplained hemorrhaging, according to the Centers for Disease Control and Prevention (CDC). 

For more great science stories and general news, please visit our sister site, Headlines and Global News (HNGN).